Rulemaking

Bulk Drug Substances That Can Be Used To Compound Drug Products in Accordance With Section 503B of the Federal Food, Drug, and Cosmetic Act; Establishment of a Public Docket

🏛 Food and Drug Administration (FDA)FDA-2015-N-3469

Manufacturing & Supply Chains Pharmaceutical Policy

Documents

3

Total comments

51

all analyzed

Comment status

Open

Last activity

May 11, 2026

In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

All 3 Other 2 Notice 1

📄 Primary document

OtherJul 21, 2026

Bulk Drug Nominations Submission from Outsourcing Facilities Association

No comment period

Other· Jul 21, 2026
Bulk Drug Nominations Submission from Outsourcing Facilities Association→
No comment period
Notice· Oct 27, 2015
Bulk Drug Substances That Can Be Used To Compound Drug Products in Accordance With Section 503B of the Federal Food, Drug, and Cosmetic Act; Establishment of a Public Docket→
Open · 8608 days left💬 51